Approved Study Database

Ref. No. Scientific Title Principal investigator
2022.058 Decolonization of carbapenemase-producing Enterobacteriaceae through modulation of the gut microbiota and its resistome Prof. IP Margaret
葉碧瑤
2023.122 A Belt and Road platform to track and tackle MRSA disease and carriage, elucidating their antimicrobial and biocide resistance, genetic diversity and transmission dynamics between humans, animals and the environment Prof. IP Margaret
2020.561 A retrospective review of pneumococcal disease and other respiratory infection in Hong Kong hospitals Prof. IP Margaret
葉碧瑤
2008.030 Factors Affecting Clinical Outcomes of Vancomyic Therapy for Methicillin-Resistant Staphylococcus Aureus Bactgeraemia Dr Ip Margaret
2020.007 One Health approach to Track and Target Antimicrobial Resistance (TnT-AMR) Prof. IP Margaret
葉碧瑤
2018.261 Isolation of CD34 stem cells from cord blood Prof. IP Margaret
叶碧瑶
2019.545 Study for Monitoring Antimicrobial Resistance Trends (SMART) Prof. IP Margaret
2019.657 Burden of Streptococcus agalactiae (GBS) disease in Hong Kong Prof. IP Margaret
葉碧瑤
2018.509 A review on infections and colonization of Streptococcus agalactiae in Hong Kong, 2007-2021 Prof. IP Margaret
2019.013 Surveillance of bacterial pathogens by whole-genome sequencing Prof. IP Margaret
葉碧瑤
2018.116 Modulation of gut microbiota with probiotics: a pilot study Prof. IP Margaret
葉碧瑤
2018.628 Resistome of gut microbiota and modulation in healthy Hong Kong population Prof. IP Margaret
葉碧瑤
2017.230 Dissecting human and animal Streptococcus agalactiae (Group B streptococcus) and its resistance determinants through territory-wide sampling Prof. IP Margaret
2017.448 A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2015 - 2016. Prof. IP Margaret
2016.228 Antibiotic Susceptibility testing of Temocillin and other agents against Enterobacteriaceae in Hong Kong. Prof IP Margaret
葉碧瑤
2015.519 A review on Serotypes and In-vitro Antibiotic Susceptibilities of Streptococcus pneumoniae from Hospitalized Adult Patients in a Hong Kong Hospital, 2012 - 2014. Prof. IP Margaret
葉碧瑤
2014.306 Combating Vancomycin-Resistant Enterococci (VRE) with antibiotics with active ingredients from Traditional Chinese Medicine (TCM) Prof. IP Margaret
2016.043 Epidemiology and Detection of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hong Kong hospitals Prof. IP Margaret
葉碧瑤
2017.152 Whole Genome Sequencing-based characterization of Carbapenem-resistant Enterobacteriaceae in Hong Kong Prof. IP Margaret
2014.403 Impact of macrolide non susceptibility in Mycoplasma pneumoniae on childhood respiratory diseases Prof Ip Margaret
2013.452 The Evaluation of Computer Aided Pathology Diagnosis system for Tuberculosis Sputum Smear. Prof. Ip Margaret
2026.297 Virulence determinants of ST6011 for escalated invasive pneumococcal diseases (IPDs) caused by Streptococcus pneumoniae serotype 3 in Hong Kong Prof. Ip Margaret
2010.305 Evaluation of a nurse-led Comprehensive Child Development Service Program for high risk pregnant women in Hong Kong Ms Ip Lai Sheung
2008.494 Compare the Clinical Outcomes of Non-operative Versus Operative Treatment in Mason Type II Radial Head Fracture, Restrospective Study DR IP Kai Yuen
2014.625 The prevalence and risk factors associated with the use of Potentially Inappropriate Medication in Old Age Homes and Prince of Wales Hospital - a retrospective cohort study Student Ip Kai Cheung
2024.329 Mindfulness Intervention for Reducing Stress and Anxiety in Postnatal Women: A Six-Week Program Dr. IP KA HIM
2024.209 Molecular Characterization of CDKL5 Deficiency Disorders (CDD) with Human Brain Samples Prof. IP Jacque Pak Kan
2022.290 A Fifteen-year Retrospective Review on Livedoid Vasculopathy in a Tertiary Centre Dr. IP Edric Chi Ching
2021.028 A pilot randomized controlled trial of integrative Motivational Interviewing and Contingency Management program (MICM) for dual-diagnosed patients to enhance psychiatric medication adherence Mr. IP Chi Kin
葉志堅
2025.470 Developing and Evaluating the Effects of a Virtual AI-De-escalation Education Programme on Confidence and Knowledge on Managing Aggressive Behaviour, patients' restraint rate and staff wellbeing: A Pilot Cluster Randomised Controlled Trial in Psychiatric Nursing Care Dr Ip Chi Kin
葉志堅
2025.881 The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving for Hypnotic abusers (TBC-H): A double-blinded randomized controlled trial Dr. Ip Chi Kin
葉志堅
2025.709 Acceptance and Commitment Therapy-based lifestyle counselling programme on physical activity in people with recent-onset psychosis: A randomised controlled trial Dr. IP CHI KIN
2025.718 The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving and sleep for Hypnotic abusers (TBC-H): A pilot randomized controlled trial Dr. IP Chi Kin
葉志堅
2017.381 The feasibility study over the outcomes of substance abusers in residential detox centers when compared with video medical consultation verus face-to-face consultation Mr. IP Chi Kin
葉志堅
2026.692 A Pilot Cluster Randomized Controlled Trial of Dialectical Behaviour Therapy Skills Training (DBT-ST) for Chinese Psychiatric Inpatients with Personality Disorders (PD) to Reduce Self-Harm and Disturbing Behaviours Dr. Ip Chi Kin
葉志堅
2026.470 Identification of hidden substance users: a data-driven approach Dr. Ip Chi Kin
葉志堅
2026.468 Understanding the reasons and perspectives regarding hidden substance use: a focus group approach Dr. Ip Chi Kin
葉志堅
2026.263 VR-AI Enhanced Anger Management For Patients with Severe Mental Illness: A Pilot Randomized Controlled Trial Dr. Ip Chi Kin
葉志堅
2026.244 The use of accelerated protocol of intermittent Theta Burst Stimulation on the Craving for Stimulant abusers (TBC-S): A pilot double-blinded randomised controlled trial Dr. Ip Chi Kin
葉志堅
2026.697 A Pilot Randomised Controlled Trial of Nurse-facilitated Bright Light Therapy for Improving Sleep Quality and Quantity in Adults with Non-Alcoholic Substance Use Disorder Dr. Ip Chi Kin
葉志堅
2020.383 Effect of Acceptance and Commitment Therapy-based lifestyle counselling programme for people with early psychosis on physical activity: a pilot randomized controlled trial Mr. IP Chi Kin
葉志堅
2021.627 Comparative efficacy and safety of treatments in Intracerebral Bleeding during Direct Oral Anticoagulant Usage – a population-based study Dr. IP Bonaventure Yiu Ming
葉耀明
2022.414 Effective Translation of Endovascular Thrombectomy Trials into Real-world Practice in the Asia-Pacific: a multicenter, prospective registry (ENDURE-APAC) Dr. IP Bonaventure Yiu Ming
葉耀明
2023.340 Prognostication of Intracerebral hemorrhage – a population-based study Dr. IP Bonaventure Yiu Ming
2022.352 Prevalence and Etiologies of Intracranial Stenosis in Patients with Antiphospholipid Syndrome: a cross sectional study Dr. IP Bonaventure Yiu Ming
葉耀明
2023.295 A Real-life study of Anti-CGRP medication in Asian Patients with migraine (REAP) Dr. IP Bonaventure Yiu Ming
2023.367 A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Dr. IP Bonaventure Yiu Ming
2022.241 Brain Health in Oral Anticoagulant Recipients Dr. IP Bonaventure Yiu Ming
2021.349 The Effect of Medication Prescription on First-ever Ischemic strokes - a territory-wide observational study Dr. IP Bonaventure Yiu Ming
葉耀明
2022.639 Epidemiological Update on Migraine in Hong Kong Dr. IP Bonaventure Yiu Ming
葉耀明

Page 178 of 289.